Literature DB >> 6328642

Mink with Aleutian disease have high-affinity antiviral antibodies.

B Aasted, M E Bloom.   

Abstract

Mink persistently infected with Aleutian disease virus (ADV) develop plasmacytosis (hypergammaglobulinaemia) and immune complex disease. Mink of different colour phases were infected with different strains of ADV and bled at different times after infection. The average antibody affinities (Kav) were measured in the sera and found to fall in the range of 2 X 10(9) - 2 X 10(10) M-1, thus indicating good-quality antibodies. In sera of non-Aleutian genotype mink a decline in Kav during development of plasmacytosis was observed. Moreover, the antibody heterogeneity (alpha values) tended to decrease during the disease progress. In contrast, the Kav values in sera of infected Aleutian genotype mink remained relatively high after hypergammaglobulinaemia developed, and the antibody heterogeneity for certain of the mink sera indicated restricted heterogeneity (high alpha values). In agreement with the clonal selection theory, low virus burden (for instance, during infection with a low-virulence ADV strain) generated relatively higher affinity antibodies than a high virus burden for instance, the highly virulent Utah I strain of ADV). Furthermore, antibodies present in low concentration were of higher affinity than antibodies present in high concentrations. The relatively high affinity antibodies found in this study indicate that if the immune complex disease seen in AD is caused by virus-anti-virus antibodies, good-quality antibodies are likely to be responsible for the pathological findings.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328642     DOI: 10.1111/j.1365-3083.1984.tb00949.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Counter current line absorption immunoelectrophoresis in an alternative diagnostic screening test to counter current immunoelectrophoresis in Aleutian disease (AD) eradication programs.

Authors:  B Aasted; S Alexandersen; A Cohn; M Hansen
Journal:  Acta Vet Scand       Date:  1986       Impact factor: 1.695

2.  Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.

Authors:  M E Bloom; D A Martin; K L Oie; M E Huhtanen; F Costello; J B Wolfinbarger; S F Hayes; M Agbandje-McKenna
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink.

Authors:  M E Bloom; R E Race; B Aasted; J B Wolfinbarger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

4.  Restricted viral antibody specificity in many ferrets infected with the ferret Aleutian disease parvovirus. Brief report.

Authors:  D D Porter; H G Porter; A E Larsen; M E Bloom
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 5.  Immune mechanisms in the pathogenesis of viral diseases: a review.

Authors:  G Trautwein
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.